miRNA-584-5p exerts tumor suppressive functions in human neuroblastoma through repressing transcription of matrix metalloproteinase 14

• Published in: Biochimica et biophysica acta Vol. 1852; no. 9; pp. 1743 - 1754
• Main Authors: Xiang, Xuan, Mei, Hong, Qu, Hongxia, Zhao, Xiang, Li, Dan, Song, Huajie, Jiao, Wanju, Pu, Jiarui, Huang, Kai, Zheng, Liduan, Tong, Qiangsong
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier B.V 01.09.2015
• Subjects: Matrix metalloproteinase 14; microRNA-584-5p; Neuroblastoma; Transcriptional repression; Neuroblastoma; Matrix metalloproteinase 14; microRNA-584-5p; Transcriptional repression
• ISSN: 0925-4439; 0006-3002; 1879-260X
• DOI: 10.1016/j.bbadis.2015.06.002

Matrix metalloproteinase 14 (MMP-14) is a membrane-anchored MMP crucial for tumorigenesis and aggressiveness, and is highly expressed in neuroblastoma (NB), the most common extracranial solid tumor in childhood. Recent evidence shows the emerging roles of endogenous promoter-targeting microRNAs (miRNAs) in regulating gene transcription. However, the roles of miRNAs in the transcription of MMP-14 still remain largely unknown. In this study, through mining computational algorithm program and Argonaute-chromosome interaction dataset, we identified one binding site of miRNA-584-5p (miR-584-5p) within the MMP-14 promoter. In NB tissues, miR-584-5p was under-expressed and inversely correlated with MMP-14 expression, and was an independent prognostic factor for favorable outcome of patients. miR-584-5p precursor attenuated the expression of MMP-14 in a Dicer-dependent manner, resulting in decreased levels of vascular endothelial growth factor, in cultured NB cell lines. In addition, miR-584-5p suppressed the promoter activity of MMP-14, and mutation of miR-584-5p binding site abolished these effects. Mechanistically, miR-584-5p recruited Argonaute 2 to facilitate the enrichment of enhancer of zeste homolog 2, histone H3 lysine 27 trimethylation, and histone H3 lysine 9 dimethylation on MMP-14 promoter in NB cells, which was abolished by repressing the miR-584-5p-promoter interaction. Gain- and loss-of-function studies demonstrated that miR-584-5p suppressed the growth, invasion, metastasis, and angiogenesis of NB cells in vitro and in vivo. Moreover, restoration of MMP-14 expression rescued the NB cells from changes in these biological features. Taken together, these results indicate that promoter-targeting miR-584-5p exerts tumor suppressive functions in NB through repressing the transcription of MMP-14. •miR-584-5p is under-expressed in neuroblastoma tissues and cell lines.•miR-584-5p is an independent prognostic factor for favorable outcome of neuroblastoma.•miR-584-5p targets the MMP-14 promoter to repress its transcription in neuroblastoma.•miR-584-5p inhibits the progression of neuroblastoma via repressing MMP-14 expression.•miR-584-5p is a novel therapeutic target for neuroblastoma.